Amanda L Kong, MD, MS, FACS | Medical College of Wisconsin

Amanda L. Kong, MD, MS, FACS

Associate Professor; Chief, Section of Breast Surgery

view physician profile

Locations

Froedtert Hospital
Breast Care Center - Froedtert Hospital
Mequon Health Center

Specialties

Surgical Oncology
General Surgery

Languages

French, English

Secondary Appointments

General Surgery

Contact Information

Education

MD - Doctor of Medicine
MS -Master of Science
FACS - Fellow in the American College of Surgeons

Research Interests

Dr. Kong is a breast surgical oncologist with a clinical and research focus in breast cancer and benign breast diseases. She joined the CAPS group (formerly known as PCOR) while completing her Master’s Degree in Epidemiology at the Medical College of Wisconsin. Her clinical practice provides the foundation for her research to help improve the care of her patients. She has an interest in quality of care and health care disparities with respect to breast cancer outcomes. Her current research focuses on the relationship between hospital volume and breast cancer care, including differences in processes of care in high- and low-volume hospitals and their impact on mortality through the use of large administrative databases and tumor registries.

Detrimental effects of chemotherapy on human coronary microvascular function.

(Hader SN, Zinkevich N, Norwood Toro LE, Kriegel AJ, Kong A, Freed JK, Gutterman DD, Beyer AM.) Am J Physiol Heart Circ Physiol. 2019 Oct 01;317(4):H705-H710 PMID: 31397169 PMCID: PMC6843017 SCOPUS ID: 2-s2.0-85072508643 08/10/2019
Improving Communication in Breast Cancer Treatment Consultation: Use of a Computer Test of Health Numeracy.

(Schapira MM, Fletcher KE, Ganschow PS, Jacobs EA, Walker CM, Smallwood AJ, Gil D, Faghri A, Kong AL, Yen TW, McDunn S, Marcus E, Neuner JM.) J Womens Health (Larchmt). 2019 Oct;28(10):1407-1417 PMID: 31237471 PMCID: PMC6797073 SCOPUS ID: 2-s2.0-85073582949 06/27/2019
Surgery in the Older Patient with Breast Cancer.

(Frebault J, Bergom C, Kong AL.) Curr Oncol Rep. 2019 Jun 25;21(8):69 PMID: 31240413 SCOPUS ID: 2-s2.0-85068001117 06/27/2019
Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes.

(Ferrigni E, Bergom C, Yin Z, Szabo A, Kong AL.) Clin Breast Cancer. 2019 06;19(3):157-164 PMID: 30819504 SCOPUS ID: 2-s2.0-85061903904 03/02/2019
Discussion of preoperative mammography in women undergoing reduction mammaplasty.

(Klement KA, Hijjawi JB, Neuner J, Kelley K, Kong AL.) Breast J. 2019 05;25(3):439-443 PMID: 30924231 SCOPUS ID: 2-s2.0-85063633305 03/30/2019
The association of socioeconomic status with receipt of neoadjuvant chemotherapy.

(Neuner JM, Kong A, Blaes A, Riley D, Chrischilles E, Smallwood A, Lizarraga I, Schroeder M.) Breast Cancer Res Treat. 2019 Jan;173(1):179-188 PMID: 30232683 PMCID: PMC6687292 SCOPUS ID: 2-s2.0-85053679946 09/21/2018
Management of the axilla after neo-adjuvant chemotherapy for breast cancer: Sentinel node biopsy and radiotherapy considerations.

(Currey A, Patten CR, Bergom C, Wilson JF, Kong AL.) Breast J. 2018 11;24(6):902-910 PMID: 30255534 SCOPUS ID: 2-s2.0-85053805749 09/27/2018
The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer.

(Kong AL, Nattinger AB, McGinley E, Pezzin LE.) Breast Cancer Res Treat. 2018 Sep;171(2):477-488 PMID: 29869776 SCOPUS ID: 2-s2.0-85048054073 06/06/2018
Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.

(Jin Y, Hu W, Liu T, Rana U, Aguilera-Barrantes I, Kong A, Kumar SN, Wang B, Gao P, Wang X, Duan Y, Shi A, Song D, Yang M, Li S, Han B, Zhao G, Fan Z, Miao QR.) Cancer Lett. 2018 04 10;419:233-244 PMID: 29373839 PMCID: PMC5821135 SCOPUS ID: 2-s2.0-85041383365 01/27/2018
Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy.

(Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, Laud PW, Charlson JA.) J Cancer Surviv. 2018 04;12(2):268-275 PMID: 29243101 SCOPUS ID: 2-s2.0-85038093950 12/16/2017
Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.

(Quryshi N, Norwood Toro LE, Ait-Aissa K, Kong A, Beyer AM.) Int J Mol Sci. 2018 Mar 10;19(3) PMID: 29534446 PMCID: PMC5877658 SCOPUS ID: 2-s2.0-85044136313 03/15/2018
Triple-Negative Breast Cancer: Who Should Receive Neoadjuvant Chemotherapy?

(Chaudhary LN, Wilkinson KH, Kong A.) Surg Oncol Clin N Am. 2018 01;27(1):141-153 PMID: 29132557 SCOPUS ID: 2-s2.0-85034238097 11/15/2017